Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-11-07
1992-01-28
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514256, 514269, 514275, 544284, 544320, A61K 31505
Patent
active
050844580
ABSTRACT:
Substituted 2-acylpyridine-.alpha.-(N)-hetarylhydrazones are described, which are suitable as active substances for the treatment of antimicrobial and in particular antimycobacterial diseases, as well as as active substances for the treatment of malaria or malignant tumors. The compounds have a marked synergistic activity combined with inhibitors of folate synthase, dihydrofolic acid reductase, DNA-synthesis and RNA-synthesis.
REFERENCES:
patent: 3433871 (1969-03-01), Johnston
patent: 4341782 (1982-07-01), Konish et al.
patent: 4670547 (1987-06-01), Abdulla
patent: 5010082 (1991-04-01), Riebl et al.
Shapiro et al., Jour. Protozool., vol. 29, No. 1, pp. 85-90 (1982).
Bell et al., Org. Mag. Resonance, vol. 7, pp. 512-9 (1975).
Pellerano et al., Il Farmaco, vol. 40, No. 9, pp. 645-54 (1985).
Miakelson, Jour. Inorg. Nucl. Chem., vol. 43, pp. 123-126 (1981).
Pellerano et al. Chem. Abstr., vol. 91 entry 175157n (1979).
Schaper Klaus-Jurgen
Seydel Joachim K.
LandOfFree
Substituted 2-acylpyridine-.beta.-(N)-hetaryl-hydrazones and med does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-acylpyridine-.beta.-(N)-hetaryl-hydrazones and med, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-acylpyridine-.beta.-(N)-hetaryl-hydrazones and med will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1861189